We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.81B
AUM Growth
-$256M
Cap. Flow
-$388M
Cap. Flow %
-13.81%
Top 10 Hldgs %
24.18%
Holding
330
New
15
Increased
25
Reduced
221
Closed
17

Top Sells

Rank Stock Value
1
POOL icon
Pool Corp
POOL
+$42.7M
2
ZD icon
Ziff Davis
ZD
+$23.7M
3
MED icon
Medifast
MED
+$21.6M
4
XPO icon
XPO
XPO
+$20.9M
5
WIFI
Boingo Wireless, Inc.
WIFI
+$15.8M

Sector Composition

Rank Sector Weight
1 Technology 25.52%
2 Healthcare 25.28%
3 Industrials 15.3%
4 Consumer Discretionary 13.18%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COLL icon
51
Collegium Pharmaceutical
COLL
$956M
$18.9M 0.67%
799,298
-126,530
-14% -$2.92M
ALBO
52
DELISTED
Albireo Pharma Inc
ALBO
$18M 0.64%
510,467
-62,432
-11% -$2.03M
ARNA
53
DELISTED
Arena Pharmaceuticals Inc
ARNA
$17.1M 0.61%
251,416
-36,543
-13% -$2.38M
TFX icon
54
Teleflex
TFX
$5.98B
$16.8M 0.6%
41,766
+18
+0% +$7.38K
QLYS icon
55
Qualys
QLYS
$6.35B
$16.7M 0.59%
166,047
-24,344
-13% -$2.48M
RETA
56
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$16.7M 0.59%
117,649
-17,074
-13% -$1.93M
CSOD
57
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$15.5M 0.55%
300,153
-43,661
-13% -$2.02M
LMAT icon
58
LeMaitre Vascular
LMAT
$1.86B
$15.1M 0.54%
247,876
+18,370
+8% +$976K
KPTI icon
59
Karyopharm Therapeutics
KPTI
$48M
$14.5M 0.52%
93,960
-10,243
-10% -$1.49M
PCOM
60
DELISTED
Points.com Inc. Common Shares
PCOM
$14.3M 0.51%
824,597
-86,606
-10% -$1.42M
ACAD icon
61
Acadia Pharmaceuticals
ACAD
$5.03B
$12.5M 0.44%
512,882
-61,054
-11% -$1.38M
GBT
62
DELISTED
Global Blood Therapeutics, Inc.
GBT
$12.2M 0.43%
348,619
-50,686
-13% -$1.98M
FC icon
63
Franklin Covey
FC
$246M
$11.3M 0.4%
349,143
-44,753
-11% -$1.38M
AAP icon
64
Advance Auto Parts
AAP
$3.49B
$11.1M 0.39%
53,864
+36
+0.1% +$7.06K
CSGP icon
65
CoStar Group
CSGP
$12.3B
$10.7M 0.38%
128,737
-33
-0% -$2.85K
KNSA icon
66
Kiniksa Pharmaceuticals
KNSA
$5.93B
$10.2M 0.36%
734,366
+68,013
+10% +$1.03M
UTMD icon
67
Utah Medical Products
UTMD
$225M
$9.6M 0.34%
112,889
-4,107
-4% -$355K
ITRN icon
68
Ituran Location and Control
ITRN
$1.05B
$9.6M 0.34%
352,306
+24,472
+7% +$582K
ZGNX
69
DELISTED
Zogenix, Inc.
ZGNX
$9.14M 0.33%
528,972
-59,279
-10% -$1.09M
CSW
70
CSW Industrials
CSW
$5.71B
$8.98M 0.32%
75,790
-3,459
-4% -$441K
MSM icon
71
MSC Industrial Direct
MSM
$6.86B
$8.81M 0.31%
98,238
-14,454
-13% -$1.32M
INSM icon
72
Insmed
INSM
$28.6B
$8.55M 0.3%
300,572
-43,746
-13% -$1.3M
NKTR icon
73
Nektar Therapeutics
NKTR
$2.58B
$8.49M 0.3%
32,971
-4,768
-13% -$1.32M
NBIX icon
74
Neurocrine Biosciences
NBIX
$16.6B
$8.1M 0.29%
83,256
-14
-0% -$1.34K
PRGS icon
75
Progress Software
PRGS
$1.76B
$7.33M 0.26%
158,542
-39,007
-20% -$1.77M

Similar funds

Rice Hall James & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Rice Hall James & Associates held 330 positions worth $2.81B, down 8.3% from $3.07B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $388M in Q2 2021, closing 17 positions and reducing 221 holdings. Its most notable exit was Boingo Wireless, Inc., an estimated $15.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Bed Bath & Beyond worth $26.8M.

  • Rice Hall James & Associates's largest Q2 2021 buy was Bed Bath & Beyond: 319,517 shares worth $26.8M.
  • Rice Hall James & Associates added most to Rackspace Technology in Q2 2021, an estimated $25.1M increase.
  • Rice Hall James & Associates's biggest Q2 2021 reduction was Pool Corp, cutting an estimated $42.7M.
  • Rice Hall James & Associates fully exited Boingo Wireless, Inc. in Q2 2021, selling an estimated $15.8M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.81B portfolio in Q2 2021.
  • Rice Hall James & Associates opened 15 new positions and closed 17 in Q2 2021.
  • Rice Hall James & Associates's portfolio value fell 8.3% quarter-over-quarter to $2.81B.

Based on Rice Hall James & Associates's 13F filing for Q2 2021, filed 29 Jul 2021.